Gut Microbiome

Study on the characteristics and correlation of fecal microbiota and metabolites in patients with acute lung injury after cardiopulmonary bypass based on 16S rRNA sequencing and non-targeted metabolomics analysis.

TL;DR

Patients with postoperative ALI following CPB exhibit marked gut microbiota structural disruption and metabolic dysfunction, both closely associated with adverse clinical outcomes, with genera such as Bacteroides and their associated metabolites potentially serving as early predictive biomarkers.

Key Findings

ALI and NALI patients following CPB showed distinct differences in gut microbial community structure based on beta diversity analysis.

  • A prospective, single-center, case-control design enrolled 53 post-CPB patients: 21 in the ALI group and 32 in the non-ALI (NALI) group.
  • Anosim analysis showed R = 0.14, P = 0.004, indicating significant separation of microbial communities between groups.
  • Permanova analysis showed R2 = 0.058, P = 0.008, confirming distinct differences in microbial community structure.
  • Postoperative fecal samples were analyzed using 16S rRNA sequencing.

ALI patients exhibited significant shifts in phylum-level gut microbiota composition compared to NALI patients.

  • Bacillota (Firmicutes) was significantly increased in the ALI group.
  • Bacteroidota was significantly reduced in the ALI group.
  • Actinomycetota was also significantly reduced in the ALI group.
  • These phylum-level differences were identified from 16S rRNA sequencing of postoperative fecal samples.

At the genus level, specific bacteria were differentially abundant between ALI and NALI patients.

  • Streptococcus and Enterococcus were enriched in the ALI group.
  • Bacteroides and Akkermansia were diminished in the ALI group.
  • These genus-level differences were identified using 16S rRNA sequencing-based microbiome analysis of postoperative fecal samples.

Metabolomics analysis identified 130 differentially expressed metabolites between ALI and NALI patients, with the majority reduced in ALI.

  • A total of 130 differentially expressed metabolites were identified using non-targeted metabolomics analysis.
  • 109 of the 130 differentially expressed metabolites were significantly reduced in the ALI group.
  • The metabolic differences primarily involved amino acid metabolic pathways, including phenylalanine, tryptophan, and tyrosine metabolism.
  • Metabolomic analyses were performed on postoperative fecal samples.

A random forest model using gut microbiota genera demonstrated predictive value for ALI after CPB.

  • Genera including Bacteroides, Corynebacterium, and Lactobacillus were identified as having high predictive value for ALI.
  • The random forest model achieved an AUC > 0.7 for ALI prediction.
  • The model was based on genus-level microbiota data from postoperative fecal samples of 53 CPB patients.

Combined microbiota-metabolite analysis revealed significant correlations between specific genera and differentially expressed metabolites, suggesting a role for the gut-lung axis in ALI development.

  • Significant correlations were identified between specific genera and differentially expressed metabolites.
  • These correlations were identified by integrating 16S rRNA microbiome data with non-targeted metabolomics data.
  • The findings suggest a potential role for the gut-lung axis in the development of ALI following CPB.
  • Both gut microbiota disruption and metabolic dysfunction were closely associated with adverse clinical outcomes in post-CPB ALI patients.

Have a question about this study?

Citation

Yi S, Luo L, Dong Z, Wang K, Zhu Z, Gao Q, et al.. (2026). Study on the characteristics and correlation of fecal microbiota and metabolites in patients with acute lung injury after cardiopulmonary bypass based on 16S rRNA sequencing and non-targeted metabolomics analysis.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2025.1713650